ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ALT Altimmune Inc

10.32
1.43 (16.09%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 8,496,171
Bid Price 10.25
Ask Price 10.32
News -
Day High 10.50

Low
2.09

52 Week Range

High
14.84

Day Low 8.84
Share Name Share Symbol Market Stock Type
Altimmune Inc ALT NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
1.43 16.09% 10.32 19:00:00
Open Price Low Price High Price Close Price Previous Close
9.06 8.84 10.50 10.18 8.89
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
41,273 8,496,171 US$ 10.02 US$ 85,146,017 - 2.09 - 14.84
Last Trade Type Quantity Price Currency
18:59:47 formt 600 US$ 10.32 USD

Altimmune (ALT) Options Flow Summary

Overall Flow

Bullish

Net Premium

47k

Calls / Puts

150.00%

Buys / Sells

66.67%

OTM / ITM

66.67%

Sweeps Ratio

0.00%

Altimmune Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
546.42M 53.73M - -68k -84.71M -1.58 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Altimmune News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ALT Message Board. Create One! See More Posts on ALT Message Board See More Message Board Posts

Historical ALT Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week9.4010.507.928.864,158,4190.929.79%
1 Month13.5914.057.9210.154,687,895-3.27-24.06%
3 Months9.92514.847.9210.585,895,8100.3953.98%
6 Months2.5014.842.097.797,444,9827.82312.80%
1 Year4.8114.842.097.104,540,4125.51114.55%
3 Years13.7523.492.098.962,488,315-3.43-24.95%
5 Years2.9535.101.4510.142,103,2447.37249.83%

Altimmune Description

Altimmune Inc is a clinical-stage biopharmaceutical company focused on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH (non-alcoholic steatohepatitis). In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B virus (HBV).

Your Recent History

Delayed Upgrade Clock